Cheng-I Jonathan Ma

Has grant

Assistant Professor

University of Arizona
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Novel mechanisms of macrophage foam cell formation.

Open Date: 2025-09-05

Close Date: 2027-08-31

Grant: Open

Novel mechanisms of foam cell formation

Open Date: 2025-04-01

Close Date: 2028-03-31

Grant: Close

Investigating the roles of sterol transport protein STARD4 in foam cell formation

Open Date: 2024-01-01

Close Date: 2025-12-31

Grant: Close

Unravelling the Role of PI4P in Secretory Granule Biogenesis

Open Date: 2015-04-01

Close Date: 2016-03-31

Articles (7)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

The interaction between aggregated low-density lipoprotein (agLDL) and macrophages in arteries plays a major role in atherosclerosis. Macrophages digest agLDL and generate free cholesterol in an extracellular, acidic, hydrolytic compartment known as the lysosomal synapse. Macrophages form a tight seal around agLDL through actin polymerization and deliver lysosomal contents into this space in a process termed digestive exophagy. Our laboratory has identified TLR4 activation of MyD88/Syk as critical for digestive exophagy. Here we use pharmacological agents and siRNA knockdown to characterize signaling pathways downstream of Syk that are involved in digestive exophagy. Syk activates Bruton’s tyrosine kinase (BTK) and phospholipase Cγ2 (PLCγ2). We show that PLCγ2 and to a lesser extent BTK regulate digestive exophagy. PLCγ2 cleaves PI(4,5)P 2 into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP 3 ). Soluble IP 3 activates release of Ca 2+ from the endoplasmic reticulum (ER). We demonstrate that Ca 2+ release from the ER is upregulated by agLDL and plays a key role in digestive exophagy. Both DAG and Ca 2+ activate protein kinase Cα (PKCα). We find that PKCα is an important regulator of digestive exophagy. These results expand our understanding of the mechanisms of digestive exophagy, which could be useful in developing therapeutic interventions to slow development of atherosclerosis.

Year:

2024

The recruitment of macrophages to the intima of arteries is a critical event in atherosclerotic progression. These macrophages accumulate excessive lipid droplets and become “foam cells”, a hallmark of atherosclerosis. Most studies focus on lipid accumulation through macrophage interaction with modified monomeric low-density lipoprotein (LDL). However, in the intima, macrophages predominantly encounter aggregated LDL (agLDL), an interaction that has been studied far less. Macrophages digest agLDL and generate free cholesterol in an extracellular, acidic, hydrolytic compartment. They form a tight seal around agLDL through actin polymerization and deliver lysosomal contents into this space in a process termed digestive exophagy. There is some evidence that inhibiting digestive exophagy to slow cholesterol accumulation in macrophages protects them from becoming foam cells and slows the progression of atherosclerotic lesions. Thus, understanding the mechanisms of digestive exophagy is critical. Here, we describe a high-content microscopy screen on a library of repurposed drugs for compounds that inhibit lysosome exocytosis during digestive exophagy. We identified many hit compounds and further characterized the effects that five of these compounds have on various aspects of digestive exophagy. In addition, three of the five compounds do not inhibit oxidized LDL-induced foam cell formation, indicating the two pathways to foam cell formation can be targeted independently. We demonstrate that this high-content screening platform has great potential as a drug discovery tool with the ability to effectively and efficiently screen for modulators of digestive exophagy.

Year:

2024

Year:

2023

Collaborators (1)

Frederick Maxfield

Weill Cornell Medical College

UNITED STATES
View details